+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

US Bioinformatics Market (2022-2027) by Product & Service, Sector, Application, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 169 Pages
  • April 2022
  • Infogence Global Research
  • ID: 5585795
The US Bioinformatics Market is estimated to be USD 3.72 Bn in 2022 and is projected to reach USD 9.32 Bn by 2027, growing at a CAGR of 20.17%.

Market dynamics are forces that impact the prices and behaviors of the US Bioinformatics Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The US Bioinformatics Market is segmented based on Product & Service, Sector, and Application.
  • By Product & Service, the market is classified into Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatics Services.
  • By Sector, the market is classified into Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Other Sectors.
  • By Application, the market is classified into Genomics, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, Metabolomics, and Other Applications.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Agilent Technologies Inc, Beijing Genomics Institute (BGI), Biomax Informatics AG, Bio-Rad Laboratories, Biosystems Immunolab, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the US Bioinformatics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the US Bioinformatics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, The analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the US Bioinformatics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Public-Private Sector Funding for Bioinformatics
4.1.2 Increasing Demand for Personalized Medicine
4.1.3 Increasing Pharmaceutical and Biotechnology R&D Expenditure
4.1.4 Decreasing Costs of Genome Sequencing
4.2 Restraints
4.2.1 High Equipment Costs
4.3 Opportunities
4.3.1 Adoption of Blockchain Technology and Cloud Computing
4.3.2 Integration of Machine Learning and AI in Healthcare
4.3.3 Investments by Leading IT Companies in the Development of Bioinformatics Solutions
4.4 Challenges
4.4.1 Management of Large Data Volumes
4.4.2 Lack of Interoperability and Multiplatform Capabilities
4.4.3 Growing Competition from In-House Development and Publicly Available Tools
4.4.4 Shortage of Skilled Bioinformatics Professionals
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 US Bioinformatics Market, By Product & Service
6.1 Introduction
6.2 Knowledge Management Tools
6.2.1 Generalized Knowledge Management Tools
6.2.2 Specialized Knowledge Management Tools
6.3 Bioinformatics Platforms
6.3.1 Data Analysis Platforms
6.3.2 Structural & Functional Analysis Platforms
6.3.3 Other Bioinformatics Platforms
6.4 Bioinformatics Services
6.4.1 Sequencing Services
6.4.2 Data Analysis Services
6.4.3 Drug Discovery Services
6.4.4 Differential Gene Expression Analysis Services
6.4.5 Database And Management Services
6.4.6 Other Bioinformatics Services
7 US Bioinformatics Market, By Sector
7.1 Introduction
7.2 Medical Biotechnology
7.2.1 Drug Discovery & Development
7.2.2 Clinical Diagnostics & Personalized Medicine
7.2.3 Reproductive Health
7.3 Animal Biotechnology
7.4 Plant Biotechnology
7.5 Environmental Biotechnology
7.6 Forensic Biotechnology
7.7 Other Sectors
8 US Bioinformatics Market, By Application
8.1 Introduction
8.2 Genomics
8.3 Chemoinformatics & Drug Design
8.4 Proteomics
8.5 Transcriptomics
8.6 Metabolomics
8.7 Other Applications
9 Competitive Landscape
9.1 Competitive Quadrant
9.2 Market Share Analysis
9.3 Strategic Initiatives
9.3.1 M&A and Investments
9.3.2 Partnerships and Collaborations
9.3.3 Product Developments and Improvements
10 Company Profiles
10.1 Agilent Technologies Inc
10.2 Beijing Genomics Institute (BGI)
10.3 Biomax Informatics Ag
10.4 Bio-Rad Laboratories
10.5 Biosystems Immunolab
10.6 DNAnexus
10.7 Dnastar
10.8 Eurofins Scientific
10.9 Fios Genomics
10.10 GeneData Inc
10.11 Genewiz
10.12 Genomatix GmbH
10.13 Illumina Inc
10.14 Jadbio
10.15 Medgenome Labs Ltd
10.16 Microsynth
10.17 Neogenomics Laboratories
10.18 Partek
10.19 Perkin Elmer Inc
10.20 Petdx
11 Appendix
11.1 Questionnaire

Companies Mentioned

  • Agilent Technologies Inc
  • Beijing Genomics Institute (BGI)
  • Biomax Informatics Ag
  • Bio-Rad Laboratories
  • Biosystems Immunolab
  • DNAnexus
  • Dnastar
  • Eurofins Scientific
  • Fios Genomics
  • GeneData Inc
  • Genewiz
  • Genomatix GmbH
  • Illumina Inc
  • Jadbio
  • Medgenome Labs Ltd
  • Microsynth
  • Neogenomics Laboratories
  • Partek
  • Perkin Elmer Inc
  • Petdx